HIMS Valuation

Hims & Hers Health Inc

Add to Watchlist

Advanced Chart

49.920

+2.32(4.874%)1D

Overview
Forecast
Valuation
Earnings

HIMS Relative Valuation

HIMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HIMS is overvalued; if below, it's undervalued.

Historical Valuation

Hims & Hers Health Inc (HIMS) is now in the Fair zone, suggesting that its current forward PS ratio of 4.60 is considered Fairly compared with the five-year average of -6.80. The fair price of Hims & Hers Health Inc (HIMS) is between 10.33 to 57.45 according to relative valuation methord.

Relative Value

Fair Zone

10.33-57.45

Current Price：49.92

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

19.38

P/B

Median3y

9.08

Median5y

5.20

2.20

FCF Yield

Median3y

0.99

Median5y

-0.91

Competitors Valuation Multiple

The average P/S ratio for HIMS's competitors is 2.03, providing a benchmark for relative valuation. Hims & Hers Health Inc Corp (HIMS) exhibits a P/S ratio of 4.60, which is 126.35% above the industry average. Given its robust revenue growth of 110.67%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HIMS.N

Hims & Hers Health Inc

4.60

Average P/S: 2.03

110.67%